An Observational Study of Avastin (Bevacizumab) in Combination With Interferon Alpha-2a as First-Line Treatment in Patients With Advanced and/or Metastatic Renal Cell Carcinoma
Clinical trial NCT01351571 · COMPLETED
Trial details
- NCT number
- NCT01351571
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-08-01
- Primary completion
- 2011-08-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.